semaglutide achalasia Are Serious Anesthesia Risks of Semaglutide and Other GLP-1 Agonists Under-Recognized? Case Reports of Retained Solid Gastric Contents in Patients Undergoing Anesthesia Concurrent Management of Achalasia and

The FDA label includes a warning that tirzepatide may reduce the effectiveness of oral hormonal contraceptives due to delayed gastric emptying

doi: 10.1200/JCO.2017.35.15_suppl.9536 177 KlemenNDWangMRubinsteinJCOlinoKCluneJAriyanSet al

14.3 Weight Reduction and Long-term Maintenance Study of WEGOVY Injection in Pediatric Patients Aged 12 Years and Older with Obesity Overview of Clinical Trial in Pediatric Patients WEGOVY injection was evaluated to reduce excess body weight in pediatric patients aged 12 years of age and older with obesity in a 68-week, double-blind, randomized, parallel group, placebo-controlled, multi-center trial in 201 pubertal pediatric patients aged 12 years and older with BMI corresponding to 95th percentile standardized for age and sex (Study 10) (NCT#04102189)

Ask for: Full metabolic lab panel (thyroid, insulin resistance, liver, sleep study)